|
|
|
|
 |
Contents |
 |
|
|
|
|
|
|
|
|
|
129 a.a.
|
 |
|
|
|
|
|
|
|
123 a.a.
|
 |
|
|
|
|
|
|
|
44 a.a.
|
 |
|
|
|
|
|
|
|
|
* Residue conservation analysis
|
|
|
|
|
PDB id:
|
 |
|
 |
| Name: |
 |
Hydrolase/hydrolase inhibitor
|
 |
|
Title:
|
 |
Crystal structure of the complex between the coagulation factor x binding protein from snake venom and the gla domain of factor x
|
|
Structure:
|
 |
Coagulation factor x binding protein. Chain: a. Coagulation factor x binding protein. Chain: b. Coagulation factor x gla domain. Chain: g. Fragment: gla domain(residues 41-84). Ec: 3.4.21.6
|
|
Source:
|
 |
Deinagkistrodon acutus. Chinese moccasin. Organism_taxid: 36307. Bos taurus. Cattle. Organism_taxid: 9913
|
|
Biol. unit:
|
 |
Trimer (from
)
|
|
Resolution:
|
 |
|
2.30Å
|
R-factor:
|
0.201
|
R-free:
|
0.267
|
|
|
Authors:
|
 |
H.Mizuno,Z.Fujimoto,H.Atoda,T.Morita
|
Key ref:
|
 |
H.Mizuno
et al.
(2001).
Crystal structure of an anticoagulant protein in complex with the Gla domain of factor X.
Proc Natl Acad Sci U S A,
98,
7230-7234.
PubMed id:
DOI:
|
 |
|
Date:
|
 |
|
27-Feb-01
|
Release date:
|
27-Jun-01
|
|
|
|
|
|
PROCHECK
|
|
|
|
|
Headers
|
 |
|
|
References
|
|
|
|
|
|
|
|
|
|
Q9IAM1
(XA1_AGKAC) -
Agkisacutacin subunit A
|
|
|
|
Seq: Struc:
|
 |
 |
 |
152 a.a.
129 a.a.*
|
|
|
|
|
|
|
 |
 |
|
 |
|
|
 |
 |
 |
 |
Enzyme class:
|
 |
Chain G:
E.C.3.4.21.6
- Coagulation factor Xa.
|
|
 |
 |
 |
 |
 |
Reaction:
|
 |
Preferential cleavage: Arg-|-Thr and then Arg-|-Ile bonds in prothrombin to form thrombin.
|
 |
 |
 |
 |
 |
 |
 |
|
 |
|
 |
|
|
Gene Ontology (GO) functional annotation
|
|
|
|
 |
 |
 |
|
 |
 |
 |
 |
|
 |
|
Cellular component
|
extracellular region
|
1 term
|
 |
|
Biological process
|
blood coagulation
|
1 term
|
 |
|
Biochemical function
|
binding
|
4 terms
|
 |
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
| |
|
DOI no:
|
Proc Natl Acad Sci U S A
98:7230-7234
(2001)
|
|
PubMed id:
|
|
|
|
|
| |
|
Crystal structure of an anticoagulant protein in complex with the Gla domain of factor X.
|
|
H.Mizuno,
Z.Fujimoto,
H.Atoda,
T.Morita.
|
|
|
|
| |
ABSTRACT
|
|
|
| |
|
The gamma-carboxyglutamic acid (Gla) domain of blood coagulation factors is
responsible for Ca2+-dependent phospholipid membrane binding. Factor X-binding
protein (X-bp), an anticoagulant protein from snake venom, specifically binds to
the Gla domain of factor X. The crystal structure of X-bp in complex with the
Gla domain peptide of factor X at 2.3-A resolution showed that the
anticoagulation is based on the fact that two patches of the Gla domain
essential for membrane binding are buried in the complex formation. The Gla
domain thus is expected to be a new target of anticoagulant drugs, and X-bp
provides a basis for designing them. This structure also provides a
membrane-bound model of factor X.
|
|
|
|
|
| |
Selected figure(s)
|
|
|
| |
 |
 |
|
 |
|
 |
Figure 2.
Fig. 2. Overall structure of X-bp and XGD1-44 complex.
(A) Stereoview of ribbon model viewed perpendicular to the
pseudodyad of the molecule, showing the interface between X-bp
and XGD1-44. The subunits A and B of X-bp are magenta and green.
XGD1-44 is white. The side chain of Gla residues and disulfide
bonds are displayed. The bound Ca^2+ ions are denoted by blue
spheres. (B) Same view as in A, but molecular detail of
interaction between the hydrophilic patch of XGD1-44 and
positively charged X-bp, and a bridging Ca^2+. (C) Same view as
in B, but between the N terminus hydrophobic patch of XGD1-44
and the C terminus of subunit B of X-bp.
|
 |
Figure 3.
Fig. 3. Model of factor Xa bound to X-bp and XGD1-44
bound to membrane. (A) Factor Xa bound to X-bp. The Gla residues
are in red, bound Ca^2+ ions in blue (only labeled is Ca-8,
which is identified in the present study), and disulfide bonds
in green. The small molecule (dark blue) bound to the active
site of the protease domain is the FX-2212a inhibitor (17). (B)
Putative membrane-binding surface of XGD1-44. Same view as in A,
but the scale of the figure is magnified for clarity. The
hydrophobic patch includes Phe4, Leu5, and Val8, and hydrophilic
patch includes Arg28, Gla25, Gla29, Gla32, and Ca-1 as a
bridging Ca^2+, which are on either side of the yellow
horizontal line of the putative membrane surface. Ca-X is a
putative Ca^2+ ion that is taken in as another bridging Ca^2+.
|
 |
|
|
| |
Figures were
selected
by an automated process.
|
|
|
|
|
 |
 |
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
Literature references that cite this PDB file's key reference
|
|
 |
| |
PubMed id
|
 |
Reference
|
 |
|
|
|
 |
H.Wu,
X.Xu,
D.Shen,
L.Peng,
J.Song,
and
Y.Zhang
(2011).
Binding of Ca2+ and Zn2+ to factor IX/X-binding protein from venom of Agkistrodon halys Pallas: stabilization of the structure during GdnHCl-induced and thermally induced denaturation.
|
| |
J Biol Inorg Chem, 16,
69-79.
|
 |
|
|
|
|
 |
T.Sajevic,
A.Leonardi,
and
I.Križaj
(2011).
Haemostatically active proteins in snake venoms.
|
| |
Toxicon, 57,
627-645.
|
 |
|
|
|
|
 |
B.de Courcy,
L.G.Pedersen,
O.Parisel,
N.Gresh,
B.Silvi,
J.Pilmé,
and
J.P.Piquemal
(2010).
Understanding selectivity of hard and soft metal cations within biological systems using the subvalence concept. I. Application to blood coagulation: direct cation-protein electronic effects vs. indirect interactions through water networks.
|
| |
J Chem Theory Comput, 6,
1048-1063.
|
 |
|
|
|
|
 |
Y.Z.Ohkubo,
J.H.Morrissey,
and
E.Tajkhorshid
(2010).
Dynamical view of membrane binding and complex formation of human factor VIIa and tissue factor.
|
| |
J Thromb Haemost, 8,
1044-1053.
|
 |
|
|
|
|
 |
M.Ishikawa,
M.Kumashiro,
Y.Yamazaki,
H.Atoda,
and
T.Morita
(2009).
Anticoagulant Mechanism of Factor IX/factor X-binding Protein Isolated from the Venom of Trimeresurus flavoviridis.
|
| |
J Biochem, 145,
123-128.
|
 |
|
|
|
|
 |
X.Xu,
L.Zhang,
D.Shen,
H.Wu,
L.Peng,
and
J.Li
(2009).
Effect of metal ion substitutions in anticoagulation factor I from the venom of Agkistrodon acutus on the binding of activated coagulation factor X and on structural stability.
|
| |
J Biol Inorg Chem, 14,
559-571.
|
 |
|
|
|
|
 |
A.A.Watson,
J.A.Eble,
and
C.A.O'Callaghan
(2008).
Crystal structure of rhodocytin, a ligand for the platelet-activating receptor CLEC-2.
|
| |
Protein Sci, 17,
1611-1616.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
A.Venceslá,
M.A.Corral-Rodríguez,
M.Baena,
M.Cornet,
M.Domènech,
M.Baiget,
P.Fuentes-Prior,
and
E.F.Tizzano
(2008).
Identification of 31 novel mutations in the F8 gene in Spanish hemophilia A patients: structural analysis of 20 missense mutations suggests new intermolecular binding sites.
|
| |
Blood, 111,
3468-3478.
|
 |
|
|
|
|
 |
H.S.Chen,
J.M.Chen,
C.W.Lin,
K.H.Khoo,
and
I.H.Tsai
(2008).
New insights into the functions and N-glycan structures of factor X activator from Russell's viper venom.
|
| |
FEBS J, 275,
3944-3958.
|
 |
|
|
|
|
 |
Y.Z.Ohkubo,
and
E.Tajkhorshid
(2008).
Distinct structural and adhesive roles of Ca2+ in membrane binding of blood coagulation factors.
|
| |
Structure, 16,
72-81.
|
 |
|
|
|
|
 |
C.J.Lee,
V.Chandrasekaran,
R.E.Duke,
L.Perera,
and
L.G.Pedersen
(2007).
A proposed structural model of human protein Z.
|
| |
J Thromb Haemost, 5,
1558-1561.
|
 |
|
|
|
|
 |
O.Taboureau,
and
O.H.Olsen
(2007).
Computational study of coagulation factor VIIa's affinity for phospholipid membranes.
|
| |
Eur Biophys J, 36,
133-144.
|
 |
|
|
|
|
 |
L.Autin,
M.Steen,
B.Dahlbäck,
and
B.O.Villoutreix
(2006).
Proposed structural models of the prothrombinase (FXa-FVa) complex.
|
| |
Proteins, 63,
440-450.
|
 |
|
|
|
|
 |
A.Bazaa,
N.Marrakchi,
M.El Ayeb,
L.Sanz,
and
J.J.Calvete
(2005).
Snake venomics: comparative analysis of the venom proteomes of the Tunisian snakes Cerastes cerastes, Cerastes vipera and Macrovipera lebetina.
|
| |
Proteomics, 5,
4223-4235.
|
 |
|
|
|
|
 |
A.N.Zelensky,
and
J.E.Gready
(2005).
The C-type lectin-like domain superfamily.
|
| |
FEBS J, 272,
6179-6217.
|
 |
|
|
|
|
 |
N.Suzuki,
Y.Shikamoto,
Z.Fujimoto,
T.Morita,
and
H.Mizuno
(2005).
Crystallization and preliminary X-ray analysis of coagulation factor IX-binding protein from habu snake venom at pH 6.5 and 4.6.
|
| |
Acta Crystallogr Sect F Struct Biol Cryst Commun, 61,
147-149.
|
 |
|
|
|
|
 |
Q.Lu,
J.M.Clemetson,
and
K.J.Clemetson
(2005).
Snake venoms and hemostasis.
|
| |
J Thromb Haemost, 3,
1791-1799.
|
 |
|
|
|
|
 |
G.Xu,
M.Teng,
L.Niu,
P.Liu,
Y.Dong,
Q.Liu,
Q.Huang,
and
Q.Hao
(2004).
Purification, characterization, crystallization and preliminary X-ray crystallographic analysis of two novel C-type lectin-like proteins: Aall-A and Aall-B from Deinagkistrodon acutus venom.
|
| |
Acta Crystallogr D Biol Crystallogr, 60,
2035-2037.
|
 |
|
|
|
|
 |
H.C.Whinna,
E.B.Lesesky,
D.M.Monroe,
K.A.High,
P.J.Larson,
and
F.C.Church
(2004).
Role of the gamma-carboxyglutamic acid domain of activated factor X in the presence of calcium during inhibition by antithrombin-heparin.
|
| |
J Thromb Haemost, 2,
1127-1134.
|
 |
|
|
|
|
 |
T.Batuwangala,
M.Leduc,
J.M.Gibbins,
C.Bon,
and
E.Y.Jones
(2004).
Structure of the snake-venom toxin convulxin.
|
| |
Acta Crystallogr D Biol Crystallogr, 60,
46-53.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
T.Morita
(2004).
Use of snake venom inhibitors in studies of the function and tertiary structure of coagulation factors.
|
| |
Int J Hematol, 79,
123-129.
|
 |
|
|
|
|
 |
A.N.Zelensky,
and
J.E.Gready
(2003).
Comparative analysis of structural properties of the C-type-lectin-like domain (CTLD).
|
| |
Proteins, 52,
466-477.
|
 |
|
|
|
|
 |
J.Zang,
M.Teng,
and
L.Niu
(2003).
Purification, crystallization and preliminary crystallographic analysis of AHP IX-bp, a zinc ion and pH-dependent coagulation factor IX binding protein from Agkistrodon halys Pallas venom.
|
| |
Acta Crystallogr D Biol Crystallogr, 59,
730-733.
|
 |
|
|
|
|
 |
K.Horii,
D.Okuda,
T.Morita,
and
H.Mizuno
(2003).
Structural characterization of EMS16, an antagonist of collagen receptor (GPIa/IIa) from the venom of Echis multisquamatus.
|
| |
Biochemistry, 42,
12497-12502.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
M.Huang,
A.C.Rigby,
X.Morelli,
M.A.Grant,
G.Huang,
B.Furie,
B.Seaton,
and
B.C.Furie
(2003).
Structural basis of membrane binding by Gla domains of vitamin K-dependent proteins.
|
| |
Nat Struct Biol, 10,
751-756.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
S.X.Wang,
E.Hur,
C.A.Sousa,
L.Brinen,
E.J.Slivka,
and
R.J.Fletterick
(2003).
The extended interactions and Gla domain of blood coagulation factor Xa.
|
| |
Biochemistry, 42,
7959-7966.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
J.M.Lockett,
and
A.E.Mast
(2002).
Contribution of regions distal to glycine-160 to the anticoagulant activity of tissue factor pathway inhibitor.
|
| |
Biochemistry, 41,
4989-4997.
|
 |
|
|
|
|
 |
S.Liu,
Z.Zhu,
J.Sun,
Z.Zhu,
Q.Huang,
M.Teng,
and
L.Niu
(2002).
Purification, crystallization and preliminary X-ray crystallographic analysis of agkaggregin, a C-type lectin-like protein from Agkistrodon acutus venom.
|
| |
Acta Crystallogr D Biol Crystallogr, 58,
675-678.
|
 |
|
 |
 |
|
The most recent references are shown first.
Citation data come partly from CiteXplore and partly
from an automated harvesting procedure. Note that this is likely to be
only a partial list as not all journals are covered by
either method. However, we are continually building up the citation data
so more and more references will be included with time.
Where a reference describes a PDB structure, the PDB
code is
shown on the right.
|
| |